+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Veterinary Pain Management Market - Product Image

Global Veterinary Pain Management Market

  • ID: 4852288
  • Report
  • October 2019
  • Region: Global
  • 145 pages
  • TechNavio

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Bayer AG
  • Cadila Healthcare Ltd.
  • Chanelle Pharma Group
  • Daiichi Sankyo Co. Ltd.
  • Elanco Animal Health Inc.
  • Merck & Co. Inc.
  • MORE
Global Veterinary Pain Management Market: About this market
The veterinary pain management market analysis considers sales from both pain management drugs and pain management devices. Our report also provides a detailed analysis of the market in Asia, Europe, North America, and ROW. In 2019, the drugs segment had a significant market share, and this trend is expected to continue over the forecast period. With the high prevalence of painful and inflammatory diseases, the drugs segment will maintain its market position. Also, our global veterinary pain management market report looks at factors such as growth in the number of veterinarians and their income in developed countries and the growing awareness about animal health and welfare. However, the high costs associated with pet care, side effects associated with veterinary therapeutics, and stringent regulatory approval process for pain management drugs may hamper the growth of the veterinary pain management industry over the forecast period.

Global Veterinary Pain Management Market: Overview

The high prevalence of painful and inflammatory diseases
The rising obesity in pets is one of the significant risk factors for several chronic conditions. One of the common chronic conditions is osteoarthritis. This creates the need for treatments which includes NSAIDs, adjunctive pain medications, and joint supplements. The high prevalence of painful and inflammatory diseases in animals will increase the prescription of several pharmaceuticals. This will lead to the expansion of the global veterinary pain management market at a CAGR of almost 9% during the forecast period.

Rising demand for pet insurance with growing animal health expenditure
With the rising cost of animal healthcare, people are relying on pet insurance to reduce the direct financial burden. Pet insurance providers offer reimbursement-based programs. Such policies majorly cover accidental injuries, prescription drugs, and surgical procedures. This will increase marketing efforts by pet insurance companies resulting in veterinary pain management market growth.

Competitive Landscape
With the presence of several major players, the global veterinary pain management market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading veterinary pain management market vendors, that include Bayer AG, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Chanelle Pharma Group, Daiichi Sankyo Co. Ltd., Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Merck & Co. Inc., Norbrook Holdings Ltd., and Zoetis Inc.

Also, the veterinary pain management market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Cadila Healthcare Ltd.
  • Chanelle Pharma Group
  • Daiichi Sankyo Co. Ltd.
  • Elanco Animal Health Inc.
  • Merck & Co. Inc.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Drugs - Market size and forecast 2019-2024
  • Devices - Market size and forecast 2019-2024
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Growth in adoption of companion animals
  • Increasing preference for non-conventional and non-pharmaceutical
  • treatments
  • Rising demand for pet insurance with growing animal health expenditure
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cadila Healthcare Ltd.
  • Chanelle Pharma Group
  • Daiichi Sankyo Co. Ltd.
  • Dechra Pharmaceuticals Plc
  • Elanco Animal Health Inc.
  • Merck & Co. Inc.
  • Norbrook Holdings Ltd.
  • Zoetis Inc.
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits
Exhibit 01: Product overview
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Drugs - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Drugs - Year-over-year growth 2020-2024 (%)
Exhibit 22: Devices - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Devices - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Top 3 countries in North America
Exhibit 31: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 33: Top 3 countries in Europe
Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 36: Top 3 countries in Asia
Exhibit 37: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 38: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 39: Top 3 countries in ROW
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Bayer AG - Vendor overview
Exhibit 49: Bayer AG - Business segments
Exhibit 50: Bayer AG - Organizational developments
Exhibit 51: Bayer AG - Geographic focus
Exhibit 52: Bayer AG - Segment focus
Exhibit 53: Bayer AG - Key offerings
Exhibit 54: Bayer AG - Key customers
Exhibit 55: Boehringer Ingelheim International GmbH - Vendor overview
Exhibit 56: Boehringer Ingelheim International GmbH - Product segments
Exhibit 57: Boehringer Ingelheim International GmbH - Organizational developments
Exhibit 58: Boehringer Ingelheim International GmbH - Geographic focus
Exhibit 59: Boehringer Ingelheim International GmbH - Segment focus
Exhibit 60: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 61: Boehringer Ingelheim International GmbH - Key customers
Exhibit 62: Cadila Healthcare Ltd. - Vendor overview
Exhibit 63: Cadila Healthcare Ltd. - Business segments
Exhibit 64: Cadila Healthcare Ltd. - Organizational developments
Exhibit 65: Cadila Healthcare Ltd. - Geographic focus
Exhibit 66: Cadila Healthcare Ltd. - Key offerings
Exhibit 67: Cadila Healthcare Ltd. - Key customers
Exhibit 68: Chanelle Pharma Group - Vendor overview
Exhibit 69: Chanelle Pharma Group - Business segments
Exhibit 70: Chanelle Pharma Group - Organizational developments
Exhibit 71: Chanelle Pharma Group - Key offerings
Exhibit 72: Chanelle Pharma Group - Key customers
Exhibit 73: Daiichi Sankyo Co. Ltd. - Vendor overview
Exhibit 74: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 75: Daiichi Sankyo Co. Ltd. - Organizational developments
Exhibit 76: Daiichi Sankyo Co. Ltd. - Geographic focus
Exhibit 77: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 78: Daiichi Sankyo Co. Ltd. - Key customers
Exhibit 79: Dechra Pharmaceuticals Plc - Vendor overview
Exhibit 80: Dechra Pharmaceuticals Plc - Product segments
Exhibit 81: Dechra Pharmaceuticals Plc - Organizational developments
Exhibit 82: Dechra Pharmaceuticals Plc - Geographic focus
Exhibit 83: Dechra Pharmaceuticals Plc - Segment focus
Exhibit 84: Dechra Pharmaceuticals Plc - Key offerings
Exhibit 85: Dechra Pharmaceuticals Plc - Key customers
Exhibit 86: Elanco Animal Health Inc. - Vendor overview
Exhibit 87: Elanco Animal Health Inc. - Product segments
Exhibit 88: Elanco Animal Health Inc. - Organizational developments
Exhibit 89: Elanco Animal Health Inc. - Geographic focus
Exhibit 90: Elanco Animal Health Inc. - Segment focus
Exhibit 91: Elanco Animal Health Inc. - Key offerings
Exhibit 92: Elanco Animal Health Inc. - Key customers
Exhibit 93: Merck & Co. Inc. - Vendor overview
Exhibit 94: Merck & Co. Inc. - Business segments
Exhibit 95: Merck & Co. Inc. - Organizational developments
Exhibit 96: Merck & Co. Inc. - Geographic focus
Exhibit 97: Merck & Co. Inc. - Segment focus
Exhibit 98: Merck & Co. Inc. - Key offerings
Exhibit 99: Merck & Co. Inc. - Key customers
Exhibit 100: Norbrook Holdings Ltd. - Vendor overview
Exhibit 101: Norbrook Holdings Ltd. - Product segments
Exhibit 102: Norbrook Holdings Ltd. - Organizational developments
Exhibit 103: Norbrook Holdings Ltd. - Geographic focus
Exhibit 104: Norbrook Holdings Ltd. - Segment focus
Exhibit 105: Norbrook Holdings Ltd. - Key offerings
Exhibit 106: Norbrook Holdings Ltd. - Key customers
Exhibit 107: Zoetis Inc. - Vendor overview
Exhibit 108: Zoetis Inc. - Product segments
Exhibit 109: Zoetis Inc. - Organizational developments
Exhibit 110: Zoetis Inc. - Geographic focus
Exhibit 111: Zoetis Inc. - Segment focus
Exhibit 112: Zoetis Inc. - Key offerings
Exhibit 113: Zoetis Inc. - Key customers
Exhibit 114: Validation techniques employed for market sizing
Exhibit 115: Definition of market positioning of vendors
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Cadila Healthcare Ltd.
  • Chanelle Pharma Group
  • Daiichi Sankyo Co. Ltd.
  • Elanco Animal Health Inc.
  • Merck & Co. Inc.
  • MORE
The following companies are the key players in the global veterinary pain management market: Bayer AG, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Chanelle Pharma Group, Daiichi Sankyo Co. Ltd., Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Merck & Co. Inc., Norbrook Holdings Ltd., and Zoetis Inc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the rising demand for pet insurance with growing animal health expenditure.”

According to the report, one of the major drivers for this market is the high prevalence of painful and inflammatory diseases.

Further, the report states that one of the major factors hindering the growth of this market is the high costs associated with pet care.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cadila Healthcare Ltd.
  • Chanelle Pharma Group
  • Daiichi Sankyo Co. Ltd.
  • Dechra Pharmaceuticals Plc
  • Elanco Animal Health Inc.
  • Merck & Co. Inc.
  • Norbrook Holdings Ltd.
  • Zoetis Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll